Advertisement
Australia markets close in 5 hours 59 minutes
  • ALL ORDS

    7,831.90
    -100.10 (-1.26%)
     
  • ASX 200

    7,569.90
    -94.20 (-1.23%)
     
  • AUD/USD

    0.6529
    +0.0002 (+0.02%)
     
  • OIL

    79.31
    +0.31 (+0.39%)
     
  • GOLD

    2,334.40
    +23.40 (+1.01%)
     
  • Bitcoin AUD

    89,291.23
    -3,760.16 (-4.04%)
     
  • CMC Crypto 200

    1,278.45
    -60.62 (-4.53%)
     
  • AUD/EUR

    0.6092
    +0.0009 (+0.14%)
     
  • AUD/NZD

    1.1015
    +0.0015 (+0.14%)
     
  • NZX 50

    11,848.35
    -19.23 (-0.16%)
     
  • NASDAQ

    17,318.55
    -122.14 (-0.70%)
     
  • FTSE

    8,121.24
    -22.89 (-0.28%)
     
  • Dow Jones

    37,903.29
    +87.37 (+0.23%)
     
  • DAX

    17,932.17
    -186.15 (-1.03%)
     
  • Hang Seng

    17,763.03
    +16.12 (+0.09%)
     
  • NIKKEI 225

    38,274.05
    0.00 (0.00%)
     

Ionis to present at upcoming investor conferences

CARLSBAD, Calif., April 1, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)
Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)
  • 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024

  • 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024

  • BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024

  • 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

ADVERTISEMENT

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302102970.html

SOURCE Ionis Pharmaceuticals, Inc.